Skip to main content
Caplight Logo









Solio Bio

Solio Bio

Private
San Francisco, CaliforniaHealthcare & Life Scienceshttps://soliobio.com

Last Round

Seed

Sep 1, 2026

Momentum

Top 10%

of companies Caplight tracks

Company Overview

Solio Bio operates in Healthcare & Life Sciences and is based in San Francisco, California. Its latest recorded funding round was a Seed round in September 2026.

Solio Bio is a biotechnology research company that develops bio-based ingredients for skincare applications.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Fashion & Beauty, Sustainable Materials

Business Model

B2B

Customer Profile

Services & Consulting, Data as a Service

AI Layer

Non-AI

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Pricing history

Caplight clients see full MarketPrice™ history and secondary transactions.

Book a demo

For institutional investors. Book with your work email.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

Momentum history

Caplight clients track how buyer interest and sentiment change over time.

Book a demo

For institutional investors. Book with your work email.

Solio Bio Comparables

Compare Solio Bio with similar companies based on industry and business-model similarity.

Solio Bio comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Soliome
87%
Book a demo to see all comparables

For institutional investors. Book with your work email.

Solio Bio Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
SeedSep 1, 2026
Book a demo to see all funding rounds

For institutional investors. Book with your work email.

Key People

Founding team and executive leadership

Drew T.

Co-founder and Chief Scientific Officer

Founding Team

Nathan Paumier

Co-Founder & CEO

Founding Team

For institutional investors. Book with your work email.

Solio Bio Investors

Notable investors and investment history

Solio Bio investors
InvestorRounds
Replicator VCSeed
CléanteSeed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Sep 1, 2026

    Raised capital from Replicator VC and Cléante.

Book a demo to see all signals

For institutional investors. Book with your work email.

Solio Bio Filings

Explore SEC and related filing metadata, where available.

Solio Bio filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Book a demo

For institutional investors. Book with your work email.

Frequently Asked Questions

Common questions about Solio Bio's valuation, stock price, and market status.

Is Solio Bio a public or private company?

Solio Bio is a private company.

What is the current stock price of Solio Bio?

Solio Bio is a private company, so its shares have no public market price. Caplight tracks Solio Bio's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.

How much is Solio Bio worth (valuation)?

Valuation information for Solio Bio is not publicly available.

Can I buy Solio Bio stock?

Solio Bio shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.

When was Solio Bio's last funding round?

Solio Bio's most recent funding round was Seed on September 1, 2026.

Who are the main investors in Solio Bio?

Key investors in Solio Bio include Replicator VC, Cléante.

Will Solio Bio IPO soon?

No public IPO plans have been announced for Solio Bio.

How can I track Solio Bio secondary market activity?

Caplight tracks bids, offers, and trades in Solio Bio's shares on secondary markets.

Firmographic Details

HeadquartersSan Francisco, California
Employee Range2
Year Founded2025
Last FundingSep 1, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Book a demo

For institutional investors. Book with your work email.

See something wrong or outdated?